Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
-
Blossom Gold Adds World-Class Exploration Expertise to its Senior Executive Team with the Appointment of Dr. John DeDecker as Vice President, Exploration
-
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
-
U.S. Energy Corp. Closes Expanded Senior Secured Debt Facility, Completing Phase 1 Capital Stack for Big Sky Carbon Hub; Formally Suspends Use of Equity Line of Credit
-
Vancity Climate Action Plan Targets Rising Climate and Affordability Pressures
-
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality
-
Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, A Specialty Pharmacy Focused on Complex Patient Needs
-
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
-
La Mancha Investments S. à r. l. to File Early Warning Report
-
Kustom Entertainment, Inc. Announces Reverse Stock Split
-
Bodor Laser Ranked No. 1 in Global Sales Volume for Seven Consecutive Years, Demonstrating Brand Strength Through Sustained Leadership
-
Share buy-back Program
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Crypto News: Pepeto DeFi Project Announces More Than $9.3M Raised While Bitcoin Price Prediction Points To $150,000
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
-
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
-
B2Gold Announces Agreement to Sell its 70% Interest in Fingold Joint Venture to Agnico Eagle for US$325 million; B2Gold and Agnico Eagle to Enter into Nunavut Collaboration Agreement
-
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
-
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
-
BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026
-
Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power’s Operations and Strategic Plan
-
Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power’s Operations and Strategic Plan
-
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
-
BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026
-
Solera Introduces AI Engine, a Cloud-Native Intelligence Layer Powering Faster Innovation Across the Automotive Ecosystem
-
Followme Trading League Season 18 Begins Global Registration
-
CoatingSolution4U Wins Bronze at the 2026 Edison Awards in Materials Science
-
"Splendid Jiangsu" Shines in Hong Kong and Macao, Opening a New Chapter of Cultural Exchange and Industrial Integration
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Equinor ASA: Notice of annual general meeting 12 May 2026
-
Invitation: Q1 2026 Results Release and Conference Call - Wednesday, May 13th, 2026
-
Tower Semiconductor Announces First Quarter 2026 Financial Results and Conference Call
-
Cerrado Gold Announces Q1 2026 Production Results at Its Minera Don Nicolas Mine in Argentina
-
Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cance
-
KuCoin Builds on PROOF Launch with New Competitions and Expanded Rewards of up to USD 500,000
-
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
-
Vitaquest Highlights Quality Systems Supporting Its Responsibility to Customers and Consumers
-
Howard Hughes Holdings Appoints Former Arch Capital CEO Marc Grandisson to Company’s Board of Directors
-
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting
-
OwlTing Group (NASDAQ: OWLS) Announces 12-Month Lock-Up Extension Supported by SBI and Legacy Shareholders Representing More Than 99% of Subject Shares
-
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
-
USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth Leader
-
"Splendid Jiangsu" Shines in Hong Kong and Macao, Opening a New Chapter of Cultural Exchange and Industrial Integration
-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Form 8.5 (EPT/RI)- Gamma Communications Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Copenhagen Infrastructure Partners commences construction on 1,500 MWh BESS project in Chile
-
Menroc Asset Management Expands Client Base Across Private and Corporate Investment Segments
